Recombinant MVA Viruses Expressing Clade A/G, Clade B, and C Modified HIV Env, Gag, And Pol Genes
Hong Kong
07113156.6
Filed on 2005-08-29
07113156.6
Filed on 2005-08-29
IMMUNOCONJUGATES COMPRISING CD4 AND IMMUNOGLOBULIN MOLECULES FOR THE TREATMENT OF HIV INFECTION
US Application 12/053,506
Filed on 2008-03-21
Filed on 2008-03-21
METHODS FOR TREATING AND PREVENTING FIBROSIS BY IL-21/IL-21R ANTAGONISTS
European Patent
06750009.0
Filed on 2006-04-13
06750009.0
Filed on 2006-04-13
METHODS FOR TREATING AND PREVENTING FIBROSIS BY IL-21/IL-21R ANTAGONISTS
Australia
2006236755
Filed on 2006-04-13
2006236755
Filed on 2006-04-13
IL-21 Receptor Deficiency Reduces Type-2 Immunity, Inflammmation And Tissue Fibrosis
Colombia
07.108.813
Filed on 2006-04-13
07.108.813
Filed on 2006-04-13
IL-21 Receptor Deficiency Reduces Type-2 Immunity, Inflammmation And Tissue Fibrosis
Mexico
MX/A/2007/012842
Filed on 2006-04-13
MX/A/2007/012842
Filed on 2006-04-13
Targeting Poly-Gamma-DL-Glutamic Acid To Treat Staphylococcus Epidermidis And Related Infections
US Application 11/994,984
Filed on 2008-01-07
Filed on 2008-01-07
Purified Trimeric S Protein As A Vaccine Against Severe Acute Respiratory Syndrome Virus Infections
US Application 11/475,237
Filed on 2006-06-27
Filed on 2006-06-27
Universal And Specific Quantitative Detection Of Clostridium Botulinum
Patent Cooperation Treaty
PCT/US2008/050872
Filed on 2008-01-11
PCT/US2008/050872
Filed on 2008-01-11
METHODS FOR TREATING AND PREVENTING FIBROSIS
South Korea
2007-7026544
Filed on 2006-04-13
2007-7026544
Filed on 2006-04-13